December 16, 2015
…and the City of El Centro have entered the next phase of a comprehensive management services relationship with El Centro Regional Medical Center (ECRMC). Under a new agreement, UC San Diego Health will provide strategic planning and management and consulting services to the ECRMC Board of Trustees and hospital leadership.…
May 6, 2015
UC San Diego Health System and the City of El Centro have entered into a long-term management services agreement on behalf of El Centro Regional Medical Center (ECRMC), the city-owned hospital, with the goal of enhancing the delivery of high-quality health care to patients in the Imperial Valley.
December 1, 2014
UC San Diego Health System and Imperial Valley Family Care Medical Group (IVFCMG) are pleased to announce a comprehensive affiliation that will enhance the depth and quality of multi-specialty health care services and clinical trials available to patients in the Imperial Valley and surrounding communities.
March 7, 2016
…consultations with UC San Diego Health and Moores Cancer Center.
February 27, 2023
Representatives from the City of El Centro, El Centro Regional Medical Center (ECRMC), and UC San Diego Health today announced a strategic and operational plan to stabilize and financially bolster ECRMC.
September 2, 2015
…long term partnership between UC San Diego Health and El Centro Regional Medical Center (ECRMC), patients in the Imperial Valley will receive the same specialty emergency care.
January 21, 2016
Patty Maysent has accepted the position as CEO of UC San Diego Health, the region’s only academic health system. Her appointment was approved by the UC Board of Regents and will commence January 21, 2016.
April 12, 2023
Pablo Velez, RN, PhD, has been appointed by UC San Diego Health as ECRMC’s chief executive officer effective April 17.
August 24, 2015
Patty Maysent, MPH, MBA, has been appointed interim Chief Executive Officer of UC San Diego Health, bringing to the role more than 25 years of exceptional executive experience in hospital leadership and health services management.
September 2, 2020
UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.
